SL
SVB Leerink Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
251
Monte Rosa Therapeutics
GLUE
$298M
|
AB
Andrew Berens
| $4.82 | $20 |
315%
upside
| Market Perform |
14 Oct ‘21
3 years ago |
|
252
Inspire Medical Systems
INSP
$2.37B
|
RN
Richard Newitter
| $80 | $300 |
275%
upside
| Outperform |
24 Sep ‘21
4 years ago |
|
253
Tango Therapeutics
TNGX
$743M
|
AB
Andrew Berens
| $6.68 | $25 |
274%
upside
| Outperform |
20 Sep ‘21
4 years ago |
|
254
Theravance Biopharma
TBPH
$690M
|
GP
Geoffrey Porges
| $13.71 | $10 |
27%
downside
| Outperform |
16 Sep ‘21
4 years ago |
|
255
Intuitive Surgical
ISRG
$166B
|
RN
Richard Newitter
| $462.79 | $346.67 |
25%
downside
| Market Perform |
26 Aug ‘21
4 years ago |
|
256
RxSight
RXST
$404M
|
RN
Richard Newitter
| $9.88 | $20 |
102%
upside
| Outperform |
24 Aug ‘21
4 years ago |
|
257
Alcon
ALC
$39.3B
|
RN
Richard Newitter
| $79.59 | $82 |
3%
upside
| Market Perform |
19 Aug ‘21
4 years ago |
|
258
Premier
PINC
$2.22B
|
SDD
Stephanie Davis Demko
| $26.92 | $46 |
71%
upside
| Outperform |
18 Aug ‘21
4 years ago |
|
259
Fulcrum Therapeutics
FULC
$386M
|
JS
Joseph Schwartz
| $7.13 | $37 |
419%
upside
| Outperform |
13 Aug ‘21
4 years ago |
|
260
RAPT Therapeutics
RAPT
$228M
|
TS
Thomas Smith
| $13.77 | $392 |
2,747%
upside
| Outperform |
12 Aug ‘21
4 years ago |
|
261
FibroGen
FGEN
$46.1M
|
GP
Geoffrey Porges
| $11.41 | $750 |
6,473%
upside
| Outperform |
10 Aug ‘21
4 years ago |
|
262
Becton Dickinson
BDX
$54B
|
RN
Richard Newitter
| $188.30 | $250 |
33%
upside
| Market Perform |
6 Aug ‘21
4 years ago |
|
263
Globus Medical
GMED
$7.96B
|
RN
Richard Newitter
| $58.95 | $96 |
63%
upside
| Outperform |
5 Aug ‘21
4 years ago |
|
264
Xencor
XNCR
$603M
|
JC
Jonathan Chang
| $8.45 | $53 |
527%
upside
| Outperform |
5 Aug ‘21
4 years ago |
|
265
Zimmer Biomet
ZBH
$20.6B
|
RN
Richard Newitter
| $104.03 | $196 |
88%
upside
| Outperform |
4 Aug ‘21
4 years ago |
|
266
Vertex Pharmaceuticals
VRTX
$100B
|
GP
Geoffrey Porges
| $390.97 | $175 |
55%
downside
| Underperform |
30 Jul ‘21
4 years ago |
|
267
Teleflex
TFX
$5.75B
|
RN
Richard Newitter
| $130.04 | $415 |
219%
upside
| Market Perform |
30 Jul ‘21
4 years ago |
|
268
Lantheus
LNTH
$3.65B
|
RN
Richard Newitter
| $53.73 | $34 |
37%
downside
| Outperform |
29 Jul ‘21
4 years ago |
|
269
Stryker
SYK
$149B
|
RN
Richard Newitter
| $390.53 | $300 |
23%
downside
| Outperform |
28 Jul ‘21
4 years ago |
|
270
Adverum Biotechnologies
ADVM
$73.2M
|
MF
Mani Foroohar
| $3.49 | $20 |
473%
upside
| Market Perform |
23 Jul ‘21
4 years ago |
|
271
Natera
NTRA
$24B
|
PS
Puneet Souda
| $174.78 | $160 |
8%
downside
| Outperform |
22 Jun ‘21
4 years ago |
|
272
Treace Medical Concepts
TMCI
$460M
|
RN
Richard Newitter
| $7.28 | $38 |
422%
upside
| Outperform |
24 May ‘21
4 years ago |
|
273
CalciMedica
CALC
$50.9M
|
MG
Marc Goodman
| $3.64 | $70 |
1,823%
upside
| Market Perform |
13 May ‘21
4 years ago |
|
274
Organogenesis Holdings
ORGO
$620M
|
RN
Richard Newitter
| $4.89 | $26 |
432%
upside
| Outperform |
11 May ‘21
4 years ago |
|
275
Assembly Biosciences
ASMB
$176M
|
GP
Geoffrey Porges
| $23 | $84 |
265%
upside
| Market Perform |
10 May ‘21
4 years ago |
|